Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors. 2011

Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
Division of Bioorganic Chemistry, School ofPharmacy, Saarland University, P.O. Box 151150, D-66123 Saarbruecken, Germany.

Flavones such as chrysin show structural similarities to androgens, the substrates of human aromatase, which converts androgens to estrogens. Aromatase is a key target in the treatment of hormone-dependent tumors, including breast cancer. Flavone-based aromatase inhibitors are of growing interest, and chrysin in particular provides a (natural) lead structure. This paper reports multicomponent synthesis as a means for facile modification of the chrysin core structure in order to add functional elements. A Mannich-type reaction was used to synthesize a range of mono- and disubstituted chrysin derivatives, some of which are more effective aromatase inhibitors than the benchmark compound, aminoglutethimide. Similarly, the reaction of chrysin with various isonitriles and acetylene dicarboxylates results in a new class of flavone derivatives, tricyclic pyrano-flavones which also inhibit human aromatase. Multicomponent reactions involving flavones therefore enable the synthesis of a variety of derivatives, some of which may be useful as anticancer agents.

UI MeSH Term Description Entries
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D047072 Aromatase Inhibitors Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. Aromatase Inhibitor,Inhibitor, Aromatase,Inhibitors, Aromatase
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
January 2017, Chemical biology & drug design,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
December 1982, Steroids,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
June 1985, Journal of medicinal chemistry,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
April 2004, Journal of enzyme inhibition and medicinal chemistry,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
February 2022, European journal of medicinal chemistry,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
August 2001, Steroids,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
January 2011, European journal of medicinal chemistry,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
January 2011, Beilstein journal of organic chemistry,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
September 2018, Bioorganic chemistry,
Hamdoon A Mohammed, and Lalla A Ba, and Torsten Burkholz, and Elena Schumann, and Britta Diesel, and Josef Zapp, and Alexandra K Kiemer, and Christina Ries, and Rolf W Hartmann, and Mohammed Hosny, and Claus Jacob
August 1995, The Journal of steroid biochemistry and molecular biology,
Copied contents to your clipboard!